Combined measurements of granulocytes and well-known biomarkers in the blood can predict the severity of COVID-19, according to a new study. The results may eventually contribute to more tailored treatments for COVID-19 patients.
Combined measurements of granulocytes and well-known biomarkers in the blood can predict the severity of COVID-19, according to a new study. The results may eventually contribute to more tailored treatments for COVID-19 patients.